Multiple sclerosis and Fibrocystic breast disease

Summary:

Fibrocystic breast disease is found among people with Multiple sclerosis, especially for people who are female, 60+ old.

The study analyzes which people have Fibrocystic breast disease with Multiple sclerosis. It is created by eHealthMe based on reports of 79 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,088 drugs and 1,358 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Fibrocystic breast disease?

Fibrocystic breast disease (a condition causing breast pain, cysts, and noncancerous breast lumps, affects many women) is found to be associated with 338 drugs and 431 conditions by eHealthMe. Check the latest studies of Fibrocystic breast disease.



On Jul, 06, 2026

79 people who have Multiple Sclerosis and Fibrocystic Breast Disease are studied.

Would you have Fibrocystic breast disease when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Fibrocystic Breast Disease *:

  • female: 97.47 %
  • male: 2.5300000000000002 %

Age of people who have Multiple Sclerosis and experienced Fibrocystic Breast Disease *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 1.3900000000000001 %
  • 30-39: 6.94 %
  • 40-49: 26.39 %
  • 50-59: 27.78 %
  • 60+: 37.5 %

Common co-existing conditions for these people *:

  1. Stress And Anxiety: 11 people, 13.92%
  2. Restless Leg Syndrome (a powerful urge to move your legs): 9 people, 11.39%
  3. Sleep Disorder: 4 people, 5.06%
  4. Depression: 4 people, 5.06%
  5. Diabetes: 4 people, 5.06%
  6. High Blood Cholesterol: 4 people, 5.06%
  7. High Blood Pressure: 4 people, 5.06%
  8. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 3.80%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 3.80%
  10. Osteoporosis (bones weak and more likely to break): 3 people, 3.80%

Common drugs taken by these people *:

  1. Avonex: 48 people, 60.76%
  2. Prempro: 16 people, 20.25%
  3. Clonazepam: 15 people, 18.99%
  4. Paxil: 14 people, 17.72%
  5. Grape Seed Extract: 8 people, 10.13%
  6. Rebif: 7 people, 8.86%
  7. Tysabri: 6 people, 7.59%
  8. Gilenya: 5 people, 6.33%
  9. Ampyra: 4 people, 5.06%
  10. Betaseron: 4 people, 5.06%

Common symptoms for these people *:

  1. Fall: 17 people, 21.52%
  2. Breast Cancer In Situ: 16 people, 20.25%
  3. Influenza Like Illness: 15 people, 18.99%
  4. Hyperaesthesia: 14 people, 17.72%
  5. Memory Loss: 13 people, 16.46%
  6. Joint Pain: 12 people, 15.19%
  7. Fatigue (feeling of tiredness): 10 people, 12.66%
  8. Breast Hyperplasia (accumulation of abnormal cells in a breast duct): 10 people, 12.66%
  9. Progressive Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord): 9 people, 11.39%
  10. Gait Disturbance: 9 people, 11.39%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Fibrocystic breast disease?

- Check whether Fibrocystic breast disease is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Fibrocystic breast disease:

All the conditions that are associated with Fibrocystic breast disease:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Fibrocystic breast disease and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: